24 Hrs
Source:
الاتحاد
AI advances in difficult cancer treatment
A team of researchers at the American Mayo Clinic has developed an experimental drug based on artificial intelligence that targets the GIPC1 protein, which contributes to drug-resistant growth in various types of cancer, especially pancreatic cancer. The drug works by blocking the difficult-to-access domain of the protein, leading to slowed tumor growth and improved survival rates, as well as enhancing the effectiveness of a common chemotherapy drug known as gemcitabine. The results, published in the journal "Cell Reports," suggest that AI can facilitate the discovery of small-molecule drugs that target specific proteins, reducing toxicity and accelerating the development of new treatments. However, these findings are currently in the preclinical stage and require further studies before moving on to human trials.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)